Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin

Ji Yoon Lee, Jun Wan Shin, Kyung Soo Chun, Kwang Kyun Park, WonYoon Chung, Yung Jue Bang, Jong Hwan Sung, Young Joon Surh

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Epidemiological studies have demonstrated that ginseng intake decreases the risk of cancer. Ginseng saponins (ginsenosides) have been regarded as principal components responsible for the majority of pharmacological activities exerted by ginseng. IH-901 [20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol], an intestinal bacterial metabolite derived from protopanaxadiol-type saponins of Panax ginseng C.A. Meyer, has been reported to possess antitumor effects, including inhibition of invasion, metastasis and angiogenesis and induction of tumor cell apoptosis. Tumor promotion often accompanies an elevated ornithine decarboxylase (ODC) activity, acute inflammation and induction of cyclooxygenase-2 (COX-2) activity. Here we examined the effects of IH-901 on tumor promotion and related molecular events in mouse skin in vivo. Mouse ear edema induced by the prototype tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) was repressed by IH-901 pre-treatment in a dose-dependent manner. Topical application of IH-901 onto shaven backs of female ICR mice led to the inhibition of TPA-induced expression of COX-2 and production of prostaglandin E2. The eukaryotic transcription factor NF-κB has been involved in intracellular signaling pathways associated with inflammation and carcinogenesis. IH-901 pre-treatment inhibited TPA-induced epidermal NF-κB DNA binding in mouse skin, which appeared to be mediated by blocking phosphorylation and subsequent degradation of IκBα. In an attempt to elucidate the molecular mechanisms by which IH-901 inactivates NF-κB, its effects on activation of upstream signaling kinases were explored. IH-901 also inhibited the activation of ERK1/2 and Akt signaling. When IH-901 was treated topically prior to TPA, expression and activity of ODC were inhibited dose-dependently. In addition, IH-901 given prior to each topical dose of TPA markedly lowered the number of papillomas in mouse skin induced by 7, 12-dimethylbenz[a]anthracene. Taken together, these findings suggest that IH-901 exerts anti-inflammatory effects by inhibiting TPA-induced COX-2 expression, which may contribute to its antitumor-promoting effects on mouse skin carcinogenesis.

Original languageEnglish
Pages (from-to)359-367
Number of pages9
JournalCarcinogenesis
Volume26
Issue number2
DOIs
Publication statusPublished - 2005 Feb 1

Fingerprint

Ginsenosides
Tetradecanoylphorbol Acetate
Panax
Skin
Cyclooxygenase 2
Ornithine Decarboxylase
Saponins
Neoplasms
Carcinogenesis
Inflammation
Inbred ICR Mouse
Papilloma
Dinoprostone
Carcinogens
Ear
protopanaxadiol
Epidemiologic Studies
Edema
Anti-Inflammatory Agents
Transcription Factors

All Science Journal Classification (ASJC) codes

  • Cancer Research

Cite this

Lee, Ji Yoon ; Shin, Jun Wan ; Chun, Kyung Soo ; Park, Kwang Kyun ; Chung, WonYoon ; Bang, Yung Jue ; Sung, Jong Hwan ; Surh, Young Joon. / Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin. In: Carcinogenesis. 2005 ; Vol. 26, No. 2. pp. 359-367.
@article{19c2c8032ba14705babc34fd54d47970,
title = "Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin",
abstract = "Epidemiological studies have demonstrated that ginseng intake decreases the risk of cancer. Ginseng saponins (ginsenosides) have been regarded as principal components responsible for the majority of pharmacological activities exerted by ginseng. IH-901 [20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol], an intestinal bacterial metabolite derived from protopanaxadiol-type saponins of Panax ginseng C.A. Meyer, has been reported to possess antitumor effects, including inhibition of invasion, metastasis and angiogenesis and induction of tumor cell apoptosis. Tumor promotion often accompanies an elevated ornithine decarboxylase (ODC) activity, acute inflammation and induction of cyclooxygenase-2 (COX-2) activity. Here we examined the effects of IH-901 on tumor promotion and related molecular events in mouse skin in vivo. Mouse ear edema induced by the prototype tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) was repressed by IH-901 pre-treatment in a dose-dependent manner. Topical application of IH-901 onto shaven backs of female ICR mice led to the inhibition of TPA-induced expression of COX-2 and production of prostaglandin E2. The eukaryotic transcription factor NF-κB has been involved in intracellular signaling pathways associated with inflammation and carcinogenesis. IH-901 pre-treatment inhibited TPA-induced epidermal NF-κB DNA binding in mouse skin, which appeared to be mediated by blocking phosphorylation and subsequent degradation of IκBα. In an attempt to elucidate the molecular mechanisms by which IH-901 inactivates NF-κB, its effects on activation of upstream signaling kinases were explored. IH-901 also inhibited the activation of ERK1/2 and Akt signaling. When IH-901 was treated topically prior to TPA, expression and activity of ODC were inhibited dose-dependently. In addition, IH-901 given prior to each topical dose of TPA markedly lowered the number of papillomas in mouse skin induced by 7, 12-dimethylbenz[a]anthracene. Taken together, these findings suggest that IH-901 exerts anti-inflammatory effects by inhibiting TPA-induced COX-2 expression, which may contribute to its antitumor-promoting effects on mouse skin carcinogenesis.",
author = "Lee, {Ji Yoon} and Shin, {Jun Wan} and Chun, {Kyung Soo} and Park, {Kwang Kyun} and WonYoon Chung and Bang, {Yung Jue} and Sung, {Jong Hwan} and Surh, {Young Joon}",
year = "2005",
month = "2",
day = "1",
doi = "10.1093/carcin/bgh313",
language = "English",
volume = "26",
pages = "359--367",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "2",

}

Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin. / Lee, Ji Yoon; Shin, Jun Wan; Chun, Kyung Soo; Park, Kwang Kyun; Chung, WonYoon; Bang, Yung Jue; Sung, Jong Hwan; Surh, Young Joon.

In: Carcinogenesis, Vol. 26, No. 2, 01.02.2005, p. 359-367.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin

AU - Lee, Ji Yoon

AU - Shin, Jun Wan

AU - Chun, Kyung Soo

AU - Park, Kwang Kyun

AU - Chung, WonYoon

AU - Bang, Yung Jue

AU - Sung, Jong Hwan

AU - Surh, Young Joon

PY - 2005/2/1

Y1 - 2005/2/1

N2 - Epidemiological studies have demonstrated that ginseng intake decreases the risk of cancer. Ginseng saponins (ginsenosides) have been regarded as principal components responsible for the majority of pharmacological activities exerted by ginseng. IH-901 [20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol], an intestinal bacterial metabolite derived from protopanaxadiol-type saponins of Panax ginseng C.A. Meyer, has been reported to possess antitumor effects, including inhibition of invasion, metastasis and angiogenesis and induction of tumor cell apoptosis. Tumor promotion often accompanies an elevated ornithine decarboxylase (ODC) activity, acute inflammation and induction of cyclooxygenase-2 (COX-2) activity. Here we examined the effects of IH-901 on tumor promotion and related molecular events in mouse skin in vivo. Mouse ear edema induced by the prototype tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) was repressed by IH-901 pre-treatment in a dose-dependent manner. Topical application of IH-901 onto shaven backs of female ICR mice led to the inhibition of TPA-induced expression of COX-2 and production of prostaglandin E2. The eukaryotic transcription factor NF-κB has been involved in intracellular signaling pathways associated with inflammation and carcinogenesis. IH-901 pre-treatment inhibited TPA-induced epidermal NF-κB DNA binding in mouse skin, which appeared to be mediated by blocking phosphorylation and subsequent degradation of IκBα. In an attempt to elucidate the molecular mechanisms by which IH-901 inactivates NF-κB, its effects on activation of upstream signaling kinases were explored. IH-901 also inhibited the activation of ERK1/2 and Akt signaling. When IH-901 was treated topically prior to TPA, expression and activity of ODC were inhibited dose-dependently. In addition, IH-901 given prior to each topical dose of TPA markedly lowered the number of papillomas in mouse skin induced by 7, 12-dimethylbenz[a]anthracene. Taken together, these findings suggest that IH-901 exerts anti-inflammatory effects by inhibiting TPA-induced COX-2 expression, which may contribute to its antitumor-promoting effects on mouse skin carcinogenesis.

AB - Epidemiological studies have demonstrated that ginseng intake decreases the risk of cancer. Ginseng saponins (ginsenosides) have been regarded as principal components responsible for the majority of pharmacological activities exerted by ginseng. IH-901 [20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol], an intestinal bacterial metabolite derived from protopanaxadiol-type saponins of Panax ginseng C.A. Meyer, has been reported to possess antitumor effects, including inhibition of invasion, metastasis and angiogenesis and induction of tumor cell apoptosis. Tumor promotion often accompanies an elevated ornithine decarboxylase (ODC) activity, acute inflammation and induction of cyclooxygenase-2 (COX-2) activity. Here we examined the effects of IH-901 on tumor promotion and related molecular events in mouse skin in vivo. Mouse ear edema induced by the prototype tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) was repressed by IH-901 pre-treatment in a dose-dependent manner. Topical application of IH-901 onto shaven backs of female ICR mice led to the inhibition of TPA-induced expression of COX-2 and production of prostaglandin E2. The eukaryotic transcription factor NF-κB has been involved in intracellular signaling pathways associated with inflammation and carcinogenesis. IH-901 pre-treatment inhibited TPA-induced epidermal NF-κB DNA binding in mouse skin, which appeared to be mediated by blocking phosphorylation and subsequent degradation of IκBα. In an attempt to elucidate the molecular mechanisms by which IH-901 inactivates NF-κB, its effects on activation of upstream signaling kinases were explored. IH-901 also inhibited the activation of ERK1/2 and Akt signaling. When IH-901 was treated topically prior to TPA, expression and activity of ODC were inhibited dose-dependently. In addition, IH-901 given prior to each topical dose of TPA markedly lowered the number of papillomas in mouse skin induced by 7, 12-dimethylbenz[a]anthracene. Taken together, these findings suggest that IH-901 exerts anti-inflammatory effects by inhibiting TPA-induced COX-2 expression, which may contribute to its antitumor-promoting effects on mouse skin carcinogenesis.

UR - http://www.scopus.com/inward/record.url?scp=13844280922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844280922&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgh313

DO - 10.1093/carcin/bgh313

M3 - Article

VL - 26

SP - 359

EP - 367

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 2

ER -